Sale!

CDSN Gene Hypotrichosis type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDSN Gene Hypotrichosis Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the Corneodesmosin (CDSN) gene, which are linked to Hypotrichosis Type 2. This condition is characterized by a rare form of hair loss that typically begins in childhood, leading to sparse scalp hair and, in some cases, affecting eyebrows and eyelashes. The test plays a crucial role in confirming a clinical diagnosis, allowing for a better understanding of the condition and informing potential treatment paths. Priced at 4400 AED, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities associated with Hypotrichosis Type 2. DNA Labs UAE provides this service with a focus on accuracy, confidentiality, and support for patients through their diagnostic journey.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDSN Gene Hypotrichosis type 2 Genetic Test

Introduction

Hypotrichosis type 2 is a rare genetic disorder characterized by sparse or absent hair. The CDSN gene is one of the genes associated with this condition.

Test Details

The CDSN Gene Hypotrichosis type 2 Genetic Test is a comprehensive genetic testing method that utilizes NGS (Next Generation Sequencing) technology. This allows for the simultaneous sequencing of multiple genes, including the CDSN gene, to identify any mutations or variations that may be responsible for the disorder.

Components and Price

The cost of the CDSN Gene Hypotrichosis type 2 Genetic Test is AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The report for the CDSN Gene Hypotrichosis type 2 Genetic Test is typically delivered within 3 to 4 weeks.

Test Type and Doctor

The CDSN Gene Hypotrichosis type 2 Genetic Test falls under the category of Osteology Dermatology Immunology Disorders. It is recommended to consult with a dermatologist for this test.

Test Department

The CDSN Gene Hypotrichosis type 2 Genetic Test is conducted by the Genetics department of DNA Labs UAE.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the CDSN Gene Hypotrichosis type 2 NGS Genetic DNA Test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the CDSN gene mutation.

Benefits of the Test

The CDSN Gene Hypotrichosis type 2 Genetic Test can help in confirming a diagnosis, predicting the risk of passing the condition to offspring, and guiding treatment options.

Test Name CDSN Gene Hypotrichosis type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDSN Gene Hypotrichosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDSN Gene Hypotrichosis type 2 NGS Genetic DNA Test gene CDSN
Test Details

Hypotrichosis type 2 is a rare genetic disorder characterized by sparse or absent hair. The CDSN gene is one of the genes associated with this condition.

NGS (Next Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes. In the case of Hypotrichosis type 2, an NGS genetic test can be used to analyze the CDSN gene for any mutations or variations that may be responsible for the disorder. This test can help in confirming a diagnosis, predicting the risk of passing the condition to offspring, and guiding treatment options.